OHSU researchers contributed to a study in mice and human cells that found the number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumors - distributed via Cision and Yahoo.

In a MedPage Today story on evaluating and treating children with Long COVID, Louise Vaz, M.D., recommends starting with a thorough history and physical to characterize children's symptoms and "functional activity limitations."

In a MedPage Today story on evaluating and treating children with Long COVID, Louise Vaz, M.D., recommends starting with a thorough history and physical to characterize children's symptoms and "functional activity limitations."

OHSU researchers identify a pill used to treat a common skin disease as an “incredibly promising” treatment for alcohol use disorder, with people who received the medication, called apremilast, reducing their alcohol intake by more than half — from five drinks per day to two.

Research led by Eric Gouaux, Ph.D., on the mechanism of hearing, is a contestant in the annual “STAT Madness” contest, a bracket-style competition in biomedical research.

Tualatin Life publisher Mike Antonelli, who received outpatient COVID-19 care at OHSU, published a selfie with Jennifer Ulberg, B.S.N., RN, and Joy Stahl, B.S.N., RN, and wrote that the experience reminded him of “the importance of our health care workers and medical professionals who protect our health and make our community a better place.”

A LiveStrong article on the causes and effects of brain fog cites OHSU research, which found stress can lead to a lack of sleep, which can in turn can affect cognition.

An OHSU clinical trial is among the first to test whether aerobic exercise combined with existing treatments leads to the repair of myelin in people with MS, potentially increasing function and preventing neurodegeneration. Lindsey Wooliscroft, M.D., says, “We’re testing whether exercise might modify their disease so they can integrate it into their care routine with their neurologist and physical therapist:”

The Oregonian profiles an OHSU patient and her husband who pursued a drug that is not FDA-approved for her cancer. Their story illustrates issues with drug pricing, the cost of health care for consumers, and and error on the part of OHSU, who neglected to apply a self-pay discount at the time of treatment. In a statement, OHSU said: “We regret this mistake and have apologized to the patient, corrected our error, and amended the process to ensure the 35% discount is applied to all who qualify.”

Peter Jacobs, Ph.D., is a part of the Artificial Intelligence for Medical Systems Lab at OHSU, which focuses on developing decision support systems for people with diabetes and using big data sets to improve prediction algorithms.